The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Survival (OS) and progression-free survival (PFS) results after induction chemotherapy (IC) followed by de-escalated chemoradiotherapy (RDCRT) for locally advanced (LA) HPV positive oropharynx cancer (HPVOPC.
 
Marshall R. Posner
Consulting or Advisory Role - BioNTech; Cel-Sci; Kura Oncology; Merck; Naveris
Research Funding - advaxis (Inst); AstraZeneca (Inst); Formation Biologics (Inst); Hookipa Pharma (Inst); Innate Pharma (Inst); MedImmune (Inst); Regeneron (Inst)
Patents, Royalties, Other Intellectual Property - anti-Pseudomonas antibody (Inst); anti-Staphylococcal Monoclonal antibody (Inst); Uptodate editor
(OPTIONAL) Uncompensated Relationships - My Personal Therapeutics
 
Krzysztof Misiukiewicz
Consulting or Advisory Role - Merck
 
Brett A. Miles
No Relationships to Disclose
 
Sonam Sharma
No Relationships to Disclose
 
Vishal Gupta
Employment - Mount Sinai Health System; Northwell Health (I)
 
Eric Michael Genden
No Relationships to Disclose
 
John Botzler
No Relationships to Disclose
 
Isaiah Selkridge
No Relationships to Disclose
 
Erin Moshier
No Relationships to Disclose
 
Vruti Virani
No Relationships to Disclose
 
Richard Lorne Bakst
No Relationships to Disclose